PAR 0.00% 26.0¢ paradigm biopharmaceuticals limited..

PAR. SP, page-810

  1. 773 Posts.
    lightbulb Created with Sketch. 148
    That's all nice Friendsandco, put unless we get a Peer Reviewed study, PAR management can cherry pick whatever stat's and results that they want to and announce to the ASX. I would like to see all the results, not a handful of selected results that suit management's agenda and appease a few naive shareholders. Why haven't PAR written and published a peer reviewed article? Are they hiding something?

    Secondly, we are now potentially 2 years away from TGA approval and possibly 3-4 years away from FDA approval. How are PAR management going to fund the $100mill+ required to get it there? Sellers have just taken out the largish buyer at 35.5c. Shorts are increasing. They are going in for the kill now. Buyers are running for the hills and current largish shareholders are stuck, due to lack of liquidity.

    There is no way PAR are going to survive this with their shareholders getting a return on their investment. Backdoor deals will happen - DS and PR will be sitting pretty and PAR shareholders are going to massively reamed. Writing is now clearly on the wall.

    PR's greed, incompetence and arrogance is mainly to blame and he's still allowed to run the show with his sidekick DS. It is appalling and there is absolutely no way the ASX should allow a CEO/MD to also be chairman of the board.

    IMO, a takeover offer will occur soon... Around 65c.


    Last edited by MixedBag: 23/01/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.0¢
Change
0.000(0.00%)
Mkt cap ! $91.06M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 1666 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 66697 1
View Market Depth
Last trade - 09.52am 18/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.